Hextar Healthcare Berhad (KLSE:HEXCARE)
Malaysia · Delayed Price · Currency is MYR 0.0600
0.00 (0.00%)
At close: Sep 2, 2026
Hextar Healthcare Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 66 | 105 | 198 | 291 | 371 | 454 | |
Market Cap Growth | -29.41% | -47.22% | -31.72% | -21.62% | -18.42% | -60.95% |
Enterprise Value | 42 | 101 | 183 | 257 | 249 | 149 |
Last Close Price | 0.06 | 0.10 | 0.18 | 0.29 | 0.37 | 0.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 2.45 |
Forward PE | - | 2.08 | 2.08 | 2.08 | 2.08 | 2.08 |
PS Ratio | 0.49 | 0.70 | 1.33 | 1.85 | 2.06 | 0.88 |
PB Ratio | 0.15 | 0.23 | 0.39 | 0.54 | 0.61 | 0.76 |
P/TBV Ratio | 0.15 | 0.23 | 0.39 | 0.54 | 0.61 | 0.76 |
P/FCF Ratio | 2.83 | 8.41 | - | - | - | 4.59 |
P/OCF Ratio | 2.50 | 5.52 | - | - | - | 3.38 |
PEG Ratio | - | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.31 | 0.67 | 1.23 | 1.64 | 1.38 | 0.29 |
EV/EBITDA Ratio | - | - | - | - | - | 0.61 |
EV/EBIT Ratio | - | - | - | - | - | 0.65 |
EV/FCF Ratio | 1.80 | 8.11 | - | - | - | 1.50 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.01 |
Debt / FCF Ratio | 0.14 | 0.19 | - | - | - | 0.02 |
Net Debt / Equity Ratio | -0.05 | -0.05 | -0.01 | -0.04 | -0.14 | -0.49 |
Net Debt / EBITDA Ratio | 2.52 | 3.32 | 1.15 | 0.45 | 2.99 | -1.22 |
Net Debt / FCF Ratio | -1.03 | -1.73 | 0.25 | 0.71 | 2.45 | -2.99 |
Asset Turnover | 0.27 | 0.30 | 0.27 | 0.25 | 0.27 | 0.91 |
Inventory Turnover | 1.45 | 1.73 | 1.33 | 1.43 | 1.27 | 1.91 |
Quick Ratio | 2.80 | 3.82 | 3.22 | 4.06 | 2.58 | 7.13 |
Current Ratio | 4.34 | 5.82 | 5.65 | 6.02 | 3.81 | 9.60 |
Return on Equity (ROE) | -10.64% | -9.27% | -2.65% | -11.22% | -9.24% | 37.95% |
Return on Assets (ROA) | -2.70% | -2.41% | -2.27% | -6.21% | -3.96% | 25.29% |
Return on Invested Capital (ROIC) | -5.15% | -4.20% | -3.96% | -12.13% | -10.44% | 68.88% |
Return on Capital Employed (ROCE) | -4.90% | -4.30% | -4.00% | -11.50% | -6.90% | 37.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -74.43% | -42.50% | -7.02% | -22.16% | -15.02% | 40.87% |
FCF Yield | 35.36% | 11.89% | -11.29% | -9.89% | -9.43% | 21.81% |
Buyback Yield / Dilution | -0.88% | -5.49% | -4.28% | -11.94% | -5.08% | -6.13% |
Total Shareholder Return | -0.88% | -5.49% | -4.28% | -11.94% | -5.08% | -6.13% |